Bovine Tuberculosis Diagnosis Market Size

Bovine Tuberculosis Diagnosis Market Analysis

The bovine tuberculosis diagnosis market is expected to register a CAGR of 4.2% over the forecast period.

The COVID-19 pandemic had a substantial impact on the bovine tuberculosis diagnosis market. Lockdown declarations in several nations, as well as the corresponding limited access to and closure of veterinary facilities, are mostly responsible for declining market growth. Due to the forced cancellation and reduction of veterinarian appointments, the pandemic made it harder for pet owners to receive proper veterinary diagnosis and treatment. For instance, according to a February 2022 article released by the Taylor & Francis Group, at the onset of the pandemic, around 70% of veterinary clinics in Canada and the United States closed their doors to the public to curb the spread of the virus to veterinary personnel as well as nonhuman animal patients in the clinic. However, the government and market players have taken various initiatives to continue their eradication programs during the pandemic. For instance, according to the Michigan Department of Agriculture and Rural Development (MDARD), activities under the Bovine Tuberculosis Eradication Program, such as TB testing, continued during the pandemic while following precautions to curb disease spread.

Furthermore, the increasing cattle population, coupled with increasing consumption of animal products, the increasing prevalence of zoonotic diseases, and supportive regulations and programs implemented by governments, are the factors driving the growth of the bovine tuberculosis diagnostics market over the forecast period.

Supportive regulations and programs implemented by governments are major factors driving the demand for the bovine tuberculosis diagnosis market. For instance, in May 2021, the United Kingdom's Department of Environment, Food, and Rural Affairs launched a proposal to help eradicate bovine tuberculosis in England through strategic priorities for a secure, productive, and sustainable agriculture system, a productive and sustainable food and drink industry, enhanced animal health and welfare, and plant health, as well as the government's overarching objective of supporting economic growth.

Moreover, the increasing prevalence of zoonotic diseases is also one of the factors driving the bovine tuberculosis diagnosis market. For example, the World Health Organization stated in May 2021 that identifying capacity gaps as well as agreement on good practices to prevent and prepare for zoonotic outbreaks, and the Food and Agriculture Organization of the United Nations and the World Organization for Animal Health had launched a guide for countries on taking a one-health approach to addressing zoonotic diseases.

In addition, new launches and strategic activities by major players in the market are positively affecting the growth of the studied market. For Instance, In February 2020, IDVET launched a new bovine tuberculosis qPCR test. It amplifies a target sequence in the Mycobacterium tuberculosis complex's genome (MTC). It is a qualitative duplex test that amplifies both the target DNA and an external internal control at the same time. It may be used to test lymph nodes and peripheral tissues from cattle, sheep, goats, deer, and badgers. Therefore, owing to the aforementioned factors, it is anticipated that the studied market will witness growth over the analysis period.